NCT06816394: Tarlatamab for Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma (TAURUS)
- State
- Under way
- Phase
- Phase 2
- People
- 32 planned
- Started
- 1 Jan 2026
- Primary completion
- 31 Dec 2027
- Arms
- Tarlatamab
- Results
- None posted
- 10 Feb 2025: Trial registered
- 1 Jan 2026: Trial started